<DOC>
	<DOC>NCT01389232</DOC>
	<brief_summary>This is a post-market study of the use of SeriScaffold® for soft tissue support and repair in breast reconstruction surgery.</brief_summary>
	<brief_title>The SeriScaffold® Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery in Europe</brief_title>
	<detailed_description />
	<criteria>Be female, greater or equal to 18 years of age Be willing to undergo immediate breast reconstruction with subpectoralis muscle placement of a breast implant Be willing to undergo mastectomy with healthy, well vascularized skin flaps anticipated by the surgeon Be in good health other than breast pathology and be suited to general anesthesia and planned treatments Have undergone breast radiation treatment and/or is preoperatively evaluated to require radiation treatment to the breast area during the course of the study Have a known allergy to silk Have any disease, including uncontrolled diabetes, which is clinically known to impact wound healing ability Have undergone previous breast surgery with the exception of mastectomy, breast biopsy, cyst removal, lumpectomy, mastopexy, reduction and/or augmentation Have had a prior soft tissue support device implanted in the breast Have a condition or be in a situation that, in the Investigator's opinion, may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>